The Times of Bahrain reports the pill form of Wegovy has been cleared in Bahrain, adding to the countries rolling out Novo's oral version.
Recap by typeshit. Post by The Times of Bahrain on X.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
Drugs.com
Eligibility usually starts at a BMI of 30, or 27 with a weight-related condition. The piece also covers costs, side effects and why most people stay on these drugs long term.
Good Morning America looks at GLP-1 use spreading from adults to a growing number of teens being treated for obesity.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
The injectable VK2735 is in two phase 3 studies, and in a maintenance trial dosing every other week kept up to 97% of the weight off, compared with 61% on placebo.
Google DeepMind describes using its Antigravity tool to accelerate the hunt for antimicrobial peptides. Details are in the linked DeepMind write-up.
Loading…